M. C. M. van der Ende-van Loon

How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurements

W. Curvers, E. J. Schoon, P. Nieuwkerk, 2021, Quality of Life Research.

Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study

E. Schoon, J. Stapelbroek, A. Stronkhorst, 2021, Clinical and Experimental Medicine.

Barrett Esophagus: Quality of life and factors associated with illness perception

E. Schoon, W. Curvers, B. Weusten, 2022, United European gastroenterology journal.

Factors influencing health-related quality of life in patients with Barrett’s esophagus: a qualitative focus group study

E. Schoon, W. Curvers, S. de Munnik, 2021, European journal of gastroenterology & hepatology.

Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remission

E. Schoon, A. Stronkhorst, R. Schreuder, 2023, Clinical and experimental medicine.

Cancer risk perception in relation to associated symptoms in Barrett's patients: A cross sectional study on quality of life

S. Houterman, E. Schoon, W. Curvers, 2018, United European gastroenterology journal.

Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.

G. Nieuwenhuijzen, J. Bloemen, Anne Jacobs, 2024, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prevalence and associated factors of worry for cancer in patients with a Barrett’s esophagus

M. C. M. van der Ende-van Loon, R. A. B. Oude Nijhuis, W. Curvers, 2024, Scientific reports.